Mohan R Wani Selected Research

Interleukin-3 (Interleukin 3)

1/2021	IL-3 inhibits rat osteoclast differentiation induced by TNF-α and other pro-osteoclastogenic cytokines.
1/2017	Interleukin-3 enhances the migration of human mesenchymal stem cells by regulating expression of CXCR4.
1/2016	IL-3 Decreases Cartilage Degeneration by Downregulating Matrix Metalloproteinases and Reduces Joint Destruction in Osteoarthritic Mice.
2/2012	IL-3 promotes osteoblast differentiation and bone formation in human mesenchymal stem cells.
2/2011	IL-3 attenuates collagen-induced arthritis by modulating the development of Foxp3+ regulatory T cells.
8/2010	IL-3 inhibits human osteoclastogenesis and bone resorption through downregulation of c-Fms and diverts the cells to dendritic cell lineage.
1/2009	IL-3 inhibits TNF-alpha-induced bone resorption and prevents inflammatory arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohan R Wani Research Topics

Disease

6	Bone Resorption 01/2021 - 07/2005
4	Rheumatoid Arthritis 09/2018 - 02/2011
2	Neoplasms (Cancer) 10/2019 - 01/2011
2	Osteoporosis 01/2019 - 08/2010
2	Asthma (Bronchial Asthma) 09/2018 - 05/2014
2	Inflammation (Inflammations) 05/2014 - 01/2009
2	Arthritis (Polyarthritis) 02/2011 - 01/2009
1	Starvation 01/2019
1	Atopic Dermatitis (Atopic Eczema) 09/2018
1	Ulcerative Colitis 09/2018
1	Osteoarthritis 01/2017
1	Vitiligo 01/2016
1	Obesity 12/2014
1	Body Weight (Weight, Body) 12/2014
1	Respiratory Hypersensitivity 05/2014
1	Bone Diseases (Bone Disease) 02/2012
1	Autoimmune Diseases (Autoimmune Disease) 02/2011
1	Experimental Arthritis 02/2011
1	Neoplasm Metastasis (Metastasis) 01/2011
1	Hypercalcemia (Milk Alkali Syndrome) 07/2005

Drug/Important Bio-Agent (IBA)

7	Interleukin-3 (Interleukin 3)IBA 01/2021 - 01/2009
3	CytokinesIBA 01/2016 - 01/2009
2	Estrogens (Estrogen)FDA Link 01/2019 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 02/2011 - 01/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2011 - 01/2009
2	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 08/2010 - 07/2005
2	LigandsIBA 08/2010 - 07/2005
1	Cyclin AIBA 10/2019
1	F-Box ProteinsIBA 10/2019
1	Interleukin-33IBA 09/2018
1	Triglycerides (Triacylglycerol)IBA 12/2014
1	CholesterolIBA 12/2014
1	RotenoneIBA 05/2014
1	AllergensIBA 05/2014
1	Interleukin-1 (Interleukin 1)IBA 02/2011
1	Interleukin-10 (Interleukin 10)IBA 02/2011
1	Interleukin-17 (Interleukin 17)IBA 02/2011
1	RANK LigandIBA 01/2011
1	Macrophage Colony-Stimulating FactorIBA 08/2010
1	collagen type I trimeric cross-linked peptideIBA 08/2010
1	CollagenIBA 08/2010
1	Collagen Type II (Type II Collagen)IBA 01/2009
1	Prostaglandins EIBA 01/2009
1	NF-kappa B (NF-kB)IBA 07/2005
1	Interleukin-4 (Interleukin 4)IBA 07/2005

Therapy/Procedure

1	Therapeutics 01/2016